Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer.
about
Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.Metformin inhibits salivary adenocarcinoma growth through cell cycle arrest and apoptosisThe therapeutic potential of mTOR inhibitors in breast cancer.
P2860
Clinical implications of recent studies using mTOR inhibitors to treat advanced hormone receptor-positive breast cancer.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Clinical implications of recen ...... ceptor-positive breast cancer.
@ast
Clinical implications of recen ...... ceptor-positive breast cancer.
@en
Clinical implications of recen ...... ceptor-positive breast cancer.
@nl
type
label
Clinical implications of recen ...... ceptor-positive breast cancer.
@ast
Clinical implications of recen ...... ceptor-positive breast cancer.
@en
Clinical implications of recen ...... ceptor-positive breast cancer.
@nl
prefLabel
Clinical implications of recen ...... ceptor-positive breast cancer.
@ast
Clinical implications of recen ...... ceptor-positive breast cancer.
@en
Clinical implications of recen ...... ceptor-positive breast cancer.
@nl
P2860
P356
P1476
Clinical implications of recen ...... ceptor-positive breast cancer.
@en
P2093
Francis Arena
P2860
P304
P356
10.2147/CMAR.S56802
P407
P577
2014-10-06T00:00:00Z